Morgan Stanley Downgrades Bright Health Gr to Underweight, Lowers Price Target to $4
Morgan Stanley analyst Ricky Goldwasser downgrades Bright Health Gr (NYSE:BHG) from Equal-Weight to Underweight and lowers the price target from $5 to $4.
Goldman Sachs Initiates Coverage On Bright Health Gr with Neutral Rating, Announces Price Target of $5
Goldman Sachs analyst Nathan Rich initiates coverage on Bright Health Gr (NYSE:BHG) with a Neutral rating and announces Price Target of $5.
JP Morgan Upgrades Bright Health Gr to Overweight
JP Morgan analyst Lisa Gill upgrades Bright Health Gr (NYSE:BHG) from Neutral to Overweight.
Bright Health Group Reports $750M Capital Raises
New financing from Cigna and long-term shareholder New Enterprise Associates affirms conviction in Bright Health Group's differentiated alignment model
MINNEAPOLIS--(BUSINESS WIRE)-- Bright Health Group, Inc.
Analyst Ratings For Bright Health Gr
Within the last quarter, Bright Health Gr (NYSE:BHG) has observed the following analyst ratings:
